Astrazeneca(Search results - 25)
CoronavirusApr 25, 2021, 8:51 AM IST
Biden administration's snub to Covid-hit India angers Indian Americans
The United States has been receiving tremendous backlash over social media over its stand. Some global think-tanks believe that the Biden administration is losing any goodwill it gained in the last few months with Indians.
Top StoriesApr 7, 2021, 6:11 PM IST
AstraZeneca serves legal notice to Serum Institute over delays in supplying COVID-19 vaccine
Adar Poonawalla, the Chief Executive Officer of Serum Institute of India on Tuesday said that pharmaceutical company AstraZeneca has sent Serum Institute a legal notice over delays in supplying the vaccine.
Top StoriesMar 25, 2021, 9:47 AM IST
AstraZeneca revises COVID vaccine data with lower efficacy rate of 76%
AstraZeneca Plc’s Covid-19 vaccine, which faced a fresh onslaught of questions this week, was 76% effective in a latest US study.
World NewsMar 19, 2021, 11:28 AM IST
European countries to resume AstraZeneca COVID-19 vaccinations after EMA terms it safe, effective
The committee also concluded that the vaccine is not associated with an increase in the overall risk of thrombolytic events or blood clots.
CoronavirusJan 28, 2021, 9:37 AM IST
Vaccine diplomacy: India sends 5 lakh Covishield doses to Sri Lanka
This humanitarian gesture amid the pandemic showcases India's commitment to its 'Neighbourhood First' Policy and SAGAR doctrine in which Sri Lanka has a prominent position, an MEA source said.
Coronavirus WorldJan 15, 2021, 10:47 AM IST
Brazil sends special flight to bring 2 million COVID-19 vaccine doses from India
The Serum Institute of India Pvt., the world’s largest producer of vaccines by volume, will supply 2 million doses of the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford to Brazil, according to the nation’s Health Minister Eduardo Pazuello.
Top StoriesJan 4, 2021, 10:41 AM IST
Coronavirus: ‘India has banned SII from exporting Oxford-AstraZeneca vaccine for several months’
The ban on exports, means that poorer nations will probably have to wait a few months before receiving their first shots.
Top StoriesJan 3, 2021, 5:40 PM IST
‘Watershed moment in India’s battle against COVID-19’, says Harsh Vardhan
Covishield, the vaccine developed by Oxford and AstraZeneca, is being manufactured for India and other countries by the Pune-based Serum Institute of India, while Coxavin is India’s first domestic Covid-19 vaccine made by the Hyderabad-based Bharat Biotech.
Top StoriesJan 2, 2021, 12:42 PM IST
Covishield vaccine: What you should know
The Oxford-AstraZeneca-Serum Institute 'Covishield' vaccine is all set to receive Emergency Use Authorisation in India. The Drugs Controller General of India will take a final call on the matter. A government-appointed panel has given the go-ahead to Covishield for emergency use. Here's what you should know about SII's vaccine.
Top StoriesJan 1, 2021, 5:45 PM IST
Oxford’s AstraZeneca COVID-19 vaccine gets approval in India: Sources
The Serum Institute of India, the local manufacturer of the vaccine, has already stockpiled nearly 50 million doses and a majority of them will be administered to India.
Coronavirus WorldDec 30, 2020, 1:10 PM IST
Oxford Covid vaccine gets UK nod, 100 million doses to roll out from January 4
The UK government accepted the recommendation from the Medicines and Healthcare products regulatory agency to authorise Oxford University/AstraZeneca's Covid-19 vaccine for use.
Top StoriesNov 28, 2020, 2:26 PM IST
PM goes on Covid-19 vaccine trail, review top 3 contenders
Prime Minister Narendra Modi today personally reviewed the vaccine development and manufacturing process at three of the facilities in Ahmedabad, Pune and Hyderabad. The visit was aimed getting a first-hand perspective of the preparations, challenges and roadmap in India’s endeavour to vaccinate its citizens.
IndiaNov 12, 2020, 1:30 PM IST
Coronavirus: Serum Institute produces 40 million doses of AstraZeneca COVID-19 vaccine
Serum declined to comment on whether the 40 million doses of the AstraZeneca vaccine were meant for global supply or only for India.
WORLDNov 6, 2020, 10:38 AM IST
Coronavirus: AstraZeneca to begin COVID-19 vaccine clinical trials in China
If successful, they will file for emergency approvals in as many countries as possible at the same time, its CEO, Pascal Soriot, said this week.